XML 21 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Related Party
6 Months Ended
Jun. 30, 2011
Related Party
2.  Related Party
 
Based on its stock ownership in the Company, MD Anderson meets the criteria to be deemed a related party of Bio-Path.  In the second quarter ending June 30, 2011, MD Anderson received $25,000 in cash from the Company for patent expenses previously accrued and related to the Company’s technology license, plus an additional $25,000 in expense was accrued for R&D related clinical trial expense, and $5,115 in cash for patent expense related to the Company's technology license. As of June 30, 2011, the Company had accrued expenses due to the related party totaling $100,000, comprised of $50,000 in accrued license payments related to the Company’s Technology License and $50,000 in accrued R&D related expense for the clinical trial.  See Note 6.